Inventor · disambiguated record
Tae Bo Sim
Also filed as: SIM TAE-BO
23 granted patents·10 pending applications·76 citations·filing 1999–2022
93Inventor score
Top patents by PatentIndex Score
33 records- 0191US8754209B2Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredientSIM TAE BO·Filed 2009·Granted Jun 17, 2014·30 cites·8 claims
- 0289US9586936B2Heteroarylamine derivatives as protein kinase inhibitorsKOREA INST SCI & TECH·Filed 2015·Granted Mar 7, 2017·13 cites·11 claims
- 0385US8329708B21,3,6-substituted indole derivatives having inhibitory activity for protein kinaseSIM TAE BO·Filed 2010·Granted Dec 11, 2012·5 cites·11 claims
- 0481US8586580B22,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Nov 19, 2013·8 cites·7 claims
- 0578US8765749B21,6-disubstituted indole compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Jul 1, 2014·3 cites·7 claims
- 0673US8648089B21,3,6-substituted indole derivatives having inhibitory activity for protein kinaseKOREA INST SCI & TECH·Filed 2012·Granted Feb 11, 2014·1 cites·3 claims
- 0773US7087768B2Fumagillol derivatives and preparing method thereofEQUISPHARM CO LTD·Filed 2002·Granted Aug 8, 2006·8 cites·11 claims
- 0872US10442796B22,3,5-substituted thiophene compound as protein kinase inhibitorKOREA INST SCI & TECH·Filed 2018·Granted Oct 15, 2019·1 cites·8 claims
- 0969US10155767B2Therapeutic agent of acute myeloid leukemia containing 1,3,7-trisubstituted 3,4-dihydropyrimido[4,5-D]pyrimidine-2(1H)-one derivativesKOREA INST SCI & TECH·Filed 2017·Granted Dec 18, 2018·1 cites·3 claims
- 1066US8999973B2Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinasesSON JUNG BEOM·Filed 2011·Granted Apr 7, 2015·2 cites·14 claims
- 1157US10112954B2Bicyclic heteroaryl derivatives having inhibitory activity for protein kinaseJUNG SEUNG HYUN·Filed 2011·Granted Oct 30, 2018·1 cites·7 claims
- 1255US2025136614A12,7-substituted pyrrolo[2,1-f][1,2,4]triazine compound having protein kinase inhibitory activityMAGICBULLETTHERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1354US8871950B1Process for preparing (+)-polyoxamic acidKOREA INST SCI & TECH·Filed 2013·Granted Oct 28, 2014·0 cites·7 claims
- 1454US8049014B2Aminoquinoline derivatives, preparation method thereof and pharmaceutical composition comprising the sameKOREA INST SCI & TECH·Filed 2009·Granted Nov 1, 2011·0 cites·17 claims
- 1554US2024228458A1Pyrimidine derivative having protein kinase inhibitory activity, and therapeutic pharmaceutical composition comprising sameTHERAPEX CO LTD·Filed 2022·Application pending·0 cites
- 1654US2007149613A1Fumagillol derivative and the medical use thereofHAN CHEOL-KYU·Filed 2006·Application pending·0 cites
- 1753US2022135559A1Novel pyrido[3,4-d]pyrimidin-8-one derivative having protein kinase inhibitory activity, and pharmaceutical composition for preventing, alleviating, or treating cancer, comprising sameKOREA INST SCI & TECH·Filed 2020·Application pending·0 cites
- 1850US10683282B2Multi-substituted pyrimidine derivatives with excellent kinase inhibitory activitiesKOREA INST SCI & TECH·Filed 2019·Granted Jun 16, 2020·0 cites·20 claims
- 1950US6093831AN-trityl and N-phenylfluorenyl carboxyanhydrides of amino acidsUNIV CALIFORNIA·Filed 1999·Granted Jul 25, 2000·3 cites·6 claims
- 2050US2023103742A17-amino-3,4-dihydropyrimidopyrimidin-2-one derivative having inhibitory activity for protein kinases and therapeutic pharmaceutical composition comprising sameKOREA INST SCI & TECH·Filed 2020·Application pending·0 cites
- 2149US2006276512A1Fumagillol derivatives and preparing method thereofHAN CHEOL-KYU·Filed 2006·Application pending·0 cites
- 2247US2023263792A1Use of 2,3,5-substituted thiophene compound for preventing, alleviation, or treating mastocytosisPHAROS IBIO CO LTD·Filed 2021·Application pending·0 cites
- 2347US2023120564A1Pyrido[3,4-d]pyrimidine derivative and therapeutic pharmaceutic composition comprising sameKOREA INST SCI & TECH·Filed 2020·Application pending·0 cites
- 2446US10040803B24-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitorsKOREA INST SCI & TECH·Filed 2017·Granted Aug 7, 2018·0 cites·8 claims
- 2546US6166229AN-trityl and N-phenylfluorenyl carboxyanhydrides of amino acidsUNIV CALIFORNIA·Filed 2000·Granted Dec 26, 2000·0 cites·2 claims
- 2644US12466812B2Pyridinyltriazine derivative having protein kinase inhibitory activity, and pharmaceutical composition for preventing, ameliorating, or treating cancer comprising sameKOREA INST SCI & TECH·Filed 2020·Granted Nov 11, 2025·0 cites·9 claims
- 2743US2014155635A1Resorcylic acid lactone compoundsKOREA INST SCI & TECH·Filed 2013·Application pending·0 cites
- 2842US10130631B2CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compoundsKOREA INST SCI & TECH·Filed 2017·Granted Nov 20, 2018·0 cites·4 claims
- 2942US2014148606A1Anti-tumor effects of allosteric focal adhesion kinase inhibitor, methyl violet derivativesKOREA INST SCI & TECH·Filed 2013·Application pending·0 cites
- 3041US10494346B2Substituted pyrimidine-4-carboxylic acids having anticancer activityKOREA INST SCI & TECH·Filed 2017·Granted Dec 3, 2019·0 cites·10 claims
- 3141US10059717B2Urea compounds containing 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one skeleton as protein kinase inhibitorsKOREA INST SCI & TECH·Filed 2017·Granted Aug 28, 2018·0 cites·11 claims
- 3239US11530221B2Pyrimido[4,5-d]pyrimidin-2-one derivatives as protein kinase inhibitorsKOREA INST SCI & TECH·Filed 2020·Granted Dec 20, 2022·0 cites·11 claims
- 3337US9422307B22,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Aug 23, 2016·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Tae Bo Sim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →